ginsenoside rh2 has been researched along with Disease Models, Animal in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, JH; Guan, W; Ji, CH; Liu, Y; Shi, LS; Tang, WQ; Zhang, W | 1 |
| Cui, CH; Hou, J; Kim, MH; Kim, SC; Ko, E; Lee, JH; Park, S | 1 |
| Cheng, J; Han, K; Han, M; Liang, P; Liu, S; Lu, H; Yuan, X; Zhang, Y | 1 |
| Chen, X; Liu, S; Lv, X; Xu, T; Zhang, J | 1 |
| Chen, ZC; Cheng, JT; Hsu, CT; Lo, SH; Niu, CS; Niu, HS | 1 |
| Chang, YS; Deng, JS; Hsieh, YH; Huang, GJ | 1 |
| Chen, LX; Gao, K; Li, PY; Li, SS; Li, Z; Liu, SX; Qi, YL; Qi, Z; Shao, ZJ; Sun, YS | 1 |
| Feng, SH; He, ZY; Li, W; Qiu, J; Wang, M | 1 |
| Chen, HY; Chen, WC; Chen, YH; Hsieh, WT; Lin, YN | 1 |
| Ding, Y; Gao, Y; Yi, X; Zhou, J | 1 |
| Liu, H; Yang, Z; Zhang, L; Zhao, T | 1 |
| Han, SJ; Jang, IS; Kim, DH; Ryu, JH; Yang, JH | 1 |
12 other study(ies) available for ginsenoside rh2 and Disease Models, Animal
| Article | Year |
|---|---|
Ginsenoside Rh2 administration produces crucial antidepressant-like effects in a CUMS-induced mice model of depression.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Depression; Disease Models, Animal; Ginsenosides; Hippocampus; Mice; Stress, Psychological | 2022 |
Ginsenoside Rh2 Ameliorates Atopic Dermatitis in NC/Nga Mice by Suppressing NF-kappaB-Mediated Thymic Stromal Lymphopoietin Expression and T Helper Type 2 Differentiation.
Topics: Animals; CD4-Positive T-Lymphocytes; Cell Differentiation; Cell Line; Cytokines; Dermatitis, Atopic; Dinitrochlorobenzene; Disease Models, Animal; Down-Regulation; Ginsenosides; Humans; Immunoglobulin E; Male; Mice; NF-kappa B; Skin; Th2 Cells; Thymic Stromal Lymphopoietin | 2019 |
HCBP6 deficiency exacerbates glucose and lipid metabolism disorders in non-alcoholic fatty liver mice.
Topics: Animals; Autophagy-Related Proteins; Blood Glucose; Diet, High-Fat; Disease Models, Animal; Fatty Acids; Ginsenosides; Hep G2 Cells; Humans; Insulin; Interleukin-6; Lipolysis; Liver; Male; Metabolic Syndrome; Mice, Inbred C57BL; Mice, Knockout; Mitochondrial Proteins; Non-alcoholic Fatty Liver Disease; Oxidation-Reduction; Tumor Necrosis Factor-alpha | 2020 |
Ginsenoside Rh2 alleviates ulcerative colitis by regulating the STAT3/miR-214 signaling pathway.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Colitis, Ulcerative; Cytokines; Dextran Sulfate; Disease Models, Animal; Ginsenosides; Humans; Inflammation; Male; Mice, Inbred C57BL; MicroRNAs; Signal Transduction; STAT3 Transcription Factor; Sulfasalazine | 2021 |
Ginsenoside Rh2 Improves Cardiac Fibrosis via PPARδ-STAT3 Signaling in Type 1-Like Diabetic Rats.
Topics: Animals; Biomarkers; Blood Glucose; Cardiomyopathies; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Drugs, Chinese Herbal; Fibrosis; Gene Expression; Ginsenosides; Heart Function Tests; Male; Myocardium; Myocytes, Cardiac; PPAR delta; Rats; RNA, Small Interfering; Signal Transduction; STAT3 Transcription Factor | 2017 |
Ginsenoside Rh2 Ameliorates Lipopolysaccharide-Induced Acute Lung Injury by Regulating the TLR4/PI3K/Akt/mTOR, Raf-1/MEK/ERK, and Keap1/Nrf2/HO-1 Signaling Pathways in Mice.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Antioxidants; Cytokines; Disease Models, Animal; Endotoxins; Extracellular Signal-Regulated MAP Kinases; Ginsenosides; Heme Oxygenase-1; Inflammation Mediators; Kelch-Like ECH-Associated Protein 1; Lung; Male; MAP Kinase Kinase Kinases; Membrane Proteins; Mice, Inbred ICR; NF-E2-Related Factor 2; Oxidative Stress; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-raf; Signal Transduction; Toll-Like Receptor 4; TOR Serine-Threonine Kinases | 2018 |
Study on Antidepressant Activity of Pseudo-Ginsenoside HQ on Depression-Like Behavior in Mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain-Derived Neurotrophic Factor; Depression; Disease Models, Animal; Gene Expression Regulation; Ginsenosides; Hindlimb Suspension; Humans; Interleukin-6; Lipopolysaccharides; Mice; NF-kappa B; Signal Transduction; Swimming; Triterpenes; Tumor Necrosis Factor-alpha | 2019 |
Ginsenoside Rh2 promotes nonamyloidgenic cleavage of amyloid precursor protein via a cholesterol-dependent pathway.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Cholesterol; Disease Models, Animal; Ginsenosides; Hippocampus; Metabolic Networks and Pathways; Mice; Neurons; Peptide Fragments | 2014 |
Treatment of stress urinary incontinence by ginsenoside Rh2.
Topics: Animals; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Ginsenosides; In Vitro Techniques; Mice, Inbred C57BL; Molecular Targeted Therapy; Muscle Contraction; Myosins; Nitric Oxide; Nitric Oxide Synthase Type II; Panax; Phytotherapy; Receptors, Adrenergic, alpha-1; Superoxide Dismutase; Survival of Motor Neuron 1 Protein; Swine; Urethra; Urinary Incontinence, Stress | 2014 |
Ginsenoside Rh2 Suppresses Neovascularization in Xenograft Psoriasis Model.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Gene Expression; Ginsenosides; Heterografts; Humans; Mice; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Psoriasis; Skin; T-Lymphocytes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2015 |
Ginsenoside Rh2 inhibits hepatocellular carcinoma through β-catenin and autophagy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Autophagy; beta Catenin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gene Expression; Ginsenosides; Humans; Liver Neoplasms; Mice; Neoplastic Stem Cells; Xenograft Model Antitumor Assays | 2016 |
Ginsenoside Rh2 ameliorates scopolamine-induced learning deficit in mice.
Topics: Animals; Behavior, Animal; Bifidobacterium; Biotransformation; Disease Models, Animal; Ginsenosides; Maze Learning; Memory Disorders; Mice; Mice, Inbred ICR; Panax; Phytotherapy; Plant Extracts; Scopolamine; Swimming; Synaptic Potentials | 2009 |